Phylogica Limited Stock Cash And Equivalents
PH7 Stock | EUR 0.62 0.00 0.00% |
Phylogica Limited fundamentals help investors to digest information that contributes to Phylogica's financial success or failures. It also enables traders to predict the movement of Phylogica Stock. The fundamental analysis module provides a way to measure Phylogica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phylogica stock.
Phylogica |
Phylogica Limited Company Cash And Equivalents Analysis
Phylogica's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition |
In accordance with the recently published financial statements, Phylogica Limited has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The cash and equivalents for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
All Next | Launch Module |
Phylogica Fundamentals
Return On Equity | -0.44 | |||
Return On Asset | -0.26 | |||
Operating Margin | (6.10) % | |||
Current Valuation | 114.63 M | |||
Shares Outstanding | 3.18 B | |||
Shares Owned By Insiders | 59.27 % | |||
Shares Owned By Institutions | 0.01 % | |||
Price To Book | 6.47 X | |||
Price To Sales | 92.48 X | |||
Revenue | 3.07 M | |||
Gross Profit | 3.07 M | |||
EBITDA | (13.42 M) | |||
Net Income | (13.86 M) | |||
Book Value Per Share | 0.02 X | |||
Earnings Per Share | (0) X | |||
Beta | 0.31 | |||
Market Capitalization | 284.31 M | |||
Total Asset | 45.35 M | |||
Net Asset | 45.35 M |
About Phylogica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phylogica Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phylogica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phylogica Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phylogica Stock Analysis
When running Phylogica's price analysis, check to measure Phylogica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phylogica is operating at the current time. Most of Phylogica's value examination focuses on studying past and present price action to predict the probability of Phylogica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phylogica's price. Additionally, you may evaluate how the addition of Phylogica to your portfolios can decrease your overall portfolio volatility.